Mallinckrodt Stock Forecast for 2023 - 2025 - 2030
Updated on 03/29/2024
Mallinckrodt Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for Mallinckrodt, with the average target coming in at $0.00. If it were to be achieved, this would result in a potential downside of approximately -,100 percent from the most recent closing price in October, 2023. The high end is $0.00, and the low is $0.00. If you want to invest in MNK stock, you might also want to take a look at how its competitors are doing.
N/A
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.37 | Buy/Sell | $32.87 | 10.82% |
AMGN Stock Forecast | Amgen | Outperform |
4
|
$275.36 | Buy/Sell | $303.65 | 14.40% |
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$54.36 | Buy/Sell | $58.15 | 1.18% |
ZTS Stock Forecast | Zoetis | Outperform |
18
|
$183.49 | Buy/Sell | $220.47 | 20.72% |
SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.59k | Buy/Sell | Rp1.52k | -1.42% |
Mallinckrodt Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Mallinckrodt's Revenue has seen a drop from $2.21B to $1.91B – a 13.51% decrease. For next year, analysts predict Revenue of $2.11B, which would mean an increase of 10.32%. Over the next eight years, experts predict that Mallinckrodt's Revenue will grow at a rate of 10.98%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BIIB Stock Forecast | Biogen | Outperform |
10
|
$230.07 | Buy/Sell | $299.62 | 29.09% |
BAYN Stock Forecast | Bayer | Hold |
5
|
26.82€ | Buy/Sell | 45.15€ | 26.77% |
TEVA Stock Forecast | Teva Pharmaceutical Industries | Outperform |
12
|
$13.35 | Buy/Sell | $11.59 | 19.85% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.97 | Buy/Sell | $11.73 | 0.25% |
JAZZ Stock Forecast | Jazz Pharmaceuticals | Outperform |
14
|
$116.63 | Buy/Sell | $188.32 | 59.52% |
AUROPHARMA Stock Forecast | Aurobindo Pharma | Outperform |
18
|
Rp1.06k | Buy/Sell | Rp1.09k | 10.08% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.10 | Buy/Sell | £28.11 | 55.34% |
ALKS Stock Forecast | Alkermes | Outperform |
10
|
$28.60 | Buy/Sell | $33.27 | 18.88% |
RICHTER Stock Forecast | Outperform |
18
|
Ft9.66k | Buy/Sell | Ft11.02k | 20.86% |
Mallinckrodt EBITDA Forecast for 2023 - 2025 - 2030
Mallinckrodt's EBITDA has seen impressive growth In the last two years, rising from $482.60M to $613.90M – a growth of 27.21%. In the next year, analysts believe that EBITDA will reach $651.16M – an increase of 6.07%. For the next eight years, the forecast is for EBITDA to grow by 6.53%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
APN Stock Forecast | Aspen Pharmacare Holdings | Outperform |
18
|
R205.91 | Buy/Sell | R202.49 | 6.36% |
SFZN Stock Forecast | Siegfried Holding | Outperform |
18
|
CHF921.50 | Buy/Sell | CHF891.22 | 8.52% |
KRKG Stock Forecast | Krka, d. d. | Buy |
18
|
123.00€ | Buy/Sell | 119.80€ | 15.85% |
Mallinckrodt EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Mallinckrodt's EBIT has decreased by 86.06%, going from $-390.30M to $-54.40M. For the next year, analysts predict that EBIT will reach $-88.02M – an increase of 61.80%. Over the next eight years, experts believe that Mallinckrodt's EBIT will grow at a rate of 76.21%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
JMAT Stock Forecast | Johnson Matthey Plc | Hold |
16
|
£16.83 | Buy/Sell | £19.13 | 5.47% |
PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.59 | Buy/Sell | $44.75 | 27.49% |
BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$9.12 | Buy/Sell | $9.50 | -1.32% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IART Stock Forecast | Integra LifeSciences Holdings | Hold |
16
|
$36.22 | Buy/Sell | $46.60 | 20.10% |
GLENMARK Stock Forecast | Glenmark Pharmaceuticals | Outperform |
18
|
Rp955.30 | Buy/Sell | Rp767.80 | -5.32% |
AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$43.81 | Buy/Sell | $69.00 | 41.52% |